Boston Scientific has announced that the first implants of the WATCHMAN FLX Left LAAC Device have successfully been carried out in Europe.
Boston Scientific Launches Captivator EMR Device for Endoscopic Mucosal Resection
The device is a minimally invasive alternative to an esophagectomy, a surgical procedure that removes part of the esophagus in upper gastrointestinal (GI) tract cases.
The device is a minimally invasive alternative to an esophagectomy, a surgical procedure that removes part of the esophagus in upper gastrointestinal (GI) tract cases.
‘Boston Scientific has recently received marketing approval for its WATCHMAN FLX Left Atrial Appendage Closure Device in Europe. They have also successfully carried out the first implants of the LAAC.’
"The WATCHMAN Device is the most studied left atrial appendage closure device and has been used to help reduce the risk of stroke for tens of thousands of high-risk patients with non-valvular atrial fibrillation who seek an alternative to long-term anticoagulant therapy. We are pleased that this next-generation technology has been granted European regulatory approval and we can begin a controlled product roll-out to clinicians throughout Europe," said Dr. Kenneth Stein, chief medical officer, Rhythm Management, Boston Scientific. The implants were performed last week by Dr. Horst Sievert, department head of Cardiology and Vascular Medicine, Sankt Katharinen Hospital, in Frankfurt, Germany; by Dr. Vivek Reddy, director of Cardiac Arrhythmia Services for The Mount Sinai Hospital, at Na Homolce Hospital in Prague, Czech Republic; and Dr. Saibal Kar, director of Cardiovascular Intervention Center Research at Cedars-Sinai Heart Institute, at MC Medicor in Izola, Slovenia.
"The closed-end design of the WATCHMAN FLX Device and the ability to fully recapture and reposition this device make it a very promising option for treating indicated patients with simple to the most complex anatomies. With nearly a decade of experience implanting the original WATCHMAN Device, it has been exciting to see the advancements of this technology from Boston Scientific and take part in the first implants of this device in Europe," said Dr. Sievert in a press release.
FDA Approves Boston Scientific's Innova Bare Stent for Peripheral Artery Disease
The innova bare stent is made to be both strong and flexible, resisting fracturing while moving through tortuous anatomy and complying well with the vessel walls morphology.
The innova bare stent is made to be both strong and flexible, resisting fracturing while moving through tortuous anatomy and complying well with the vessel walls morphology.
Now Install a Stroke Prevention Device Instead of Using Blood Thinners
After two failed attempts, FDA has approved Boston Scientific's Watchman, a device that can be used as an alternative to blood thinners in stroke patients.
After two failed attempts, FDA has approved Boston Scientific's Watchman, a device that can be used as an alternative to blood thinners in stroke patients.
